Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Zohydro ER

  • Congress Questions Ethics Behind FDA Approval of Zohydro ER

    The FDA’s approval of the hydrocodone drug Zohydro ER has been met with criticism from health care...
  • Emergency Physicians Urged Not to Prescribe New Opioid, Zohydro ER, Given High Potential for Abuse

    Despite the United States encompassing just 5 percent of the world’s population, it accounts for 84 percent...
  • Critics of Zohydro ER Approval Suspect Conflict of Interest with Pharmaceutical Industry

    Whether you buy into a Food and Drug Administration conspiracy theory or not, there are many problems...

Congress Questions Ethics Behind FDA Approval of Zohydro ER

June 10, 2014 - Jessica Kinsella - 0 Comment

The FDA’s approval of the hydrocodone drug Zohydro ER has been met with criticism from health care…

Read More

Emergency Physicians Urged Not to Prescribe New Opioid, Zohydro ER, Given High Potential for Abuse

June 10, 2014 - Frank LoVecchio, DO, MPH, FACEP - 1 Comment

Despite the United States encompassing just 5 percent of the world’s population, it accounts for 84 percent…

Read More

Critics of Zohydro ER Approval Suspect Conflict of Interest with Pharmaceutical Industry

June 10, 2014 - Paul Kivela, MD, MBA, FACEP - 0 Comment

Whether you buy into a Food and Drug Administration conspiracy theory or not, there are many problems…

Read More
Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603